Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Intermittent treatment and simplified continuous treatment of newly-detected pulmonary tuberculosis with first-line drugs and limited PAS administration. I. Methods and results].
Stopczyk J, Niemirowska H, Pecyna-Sielewicz J, Janowiec M, Banaszkiewicz H, Czerwiński Z, Królikowska H, Krahowska M, Malecki S, Pezińska Z, Pilch Z, Przemyska B, Szustrowa I, Wardowa A. Stopczyk J, et al. Among authors: pilch z. Gruzlica. 1973 Jul;41(7):755-64. Gruzlica. 1973. PMID: 4730976 Polish. No abstract available.
[Intermittent treatment and simplified continuous treatment of newly-detected pulmonary tuberculosis with first-line drugs and limited administration of PAS. II. Analysis of the causes of failure].
Niemirowska H, Pecyna-Sielewicz J, Stopczyk J, Janowiec M, Banaszkiewicz H, Czerwinski Z, Krakowska M, Kròlikowskd H, Malecki S, Pezinska Z, Pilch Z, Przemyska B, Szustrowa I, Wardowa A. Niemirowska H, et al. Among authors: pilch z. Gruzlica. 1973 Jul;41(7):765-75. Gruzlica. 1973. PMID: 4730977 Polish. No abstract available.
Potassium/sodium cation carriers robustly up-regulate CD20 antigen by targeting MYC, and synergize with anti-CD20 immunotherapies to eliminate malignant B cells.
Torun A, Zdanowicz A, Miazek-Zapala N, Zapala P, Pradhan B, Jedrzejczyk M, Ciechanowicz A, Pilch Z, Skorzynski M, Słabicki M, Rymkiewicz G, Barankiewicz J, Martines C, Laurenti L, Struga M, Winiarska M, Golab J, Kucia M, Ratajczak MZ, Huczynski A, Calado DP, Efremov DG, Zerrouqi A, Pyrzynska B. Torun A, et al. Among authors: pilch z. Haematologica. 2024 Dec 19. doi: 10.3324/haematol.2024.285826. Online ahead of print. Haematologica. 2024. PMID: 39704178 Free article.
CD71+ erythroid cells promote multiple myeloma progression and impair anti-bacterial immune response.
Czubak K, Grzywa TM, Sidor-Dzitkowska K, Pilch Z, Bielak K, Hoser G, Gewartowska O, Malecka-Gieldowska M, Barankiewicz J, Garbicz F, Ciepiela O, Juszczynski P, Owczarek A, Wegrzynowicz M, Skirecki T, Golab J, Nowis D. Czubak K, et al. Among authors: pilch z. Br J Haematol. 2024 Nov 20. doi: 10.1111/bjh.19914. Online ahead of print. Br J Haematol. 2024. PMID: 39567409
Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity.
Ramji K, Grzywa TM, Sosnowska A, Paterek A, Okninska M, Pilch Z, Barankiewicz J, Garbicz F, Borg K, Bany-Laszewicz U, Zerrouqi A, Pyrzynska B, Rodziewicz-Lurzynska A, Papiernik D, Sklepkiewicz P, Kedzierska H, Staruch A, Sadowski R, Ciepiela O, Lech-Maranda E, Juszczynski P, Mackiewicz U, Maczewski M, Nowis D, Golab J. Ramji K, et al. Among authors: pilch z. Sci Rep. 2022 Nov 16;12(1):19660. doi: 10.1038/s41598-022-24137-1. Sci Rep. 2022. PMID: 36385153 Free PMC article.
Immune checkpoint inhibition improves antimyeloma activity of bortezomib and STING agonist combination in Vk*MYC preclinical model.
Sokolowska O, Rodziewicz-Lurzynska A, Pilch Z, Kedzierska H, Chlebowska-Tuz J, Sosnowska A, Szumera-Cieckiewicz A, Sokol K, Barankiewicz J, Salomon-Perzynski A, Ciepiela O, Lech-Maranda E, Golab J, Nowis D. Sokolowska O, et al. Among authors: pilch z. Clin Exp Med. 2023 Sep;23(5):1563-1572. doi: 10.1007/s10238-022-00878-1. Epub 2022 Aug 31. Clin Exp Med. 2023. PMID: 36044158 Free PMC article.
PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells.
Bajor M, Graczyk-Jarzynka A, Marhelava K, Burdzinska A, Muchowicz A, Goral A, Zhylko A, Soroczynska K, Retecki K, Krawczyk M, Klopotowska M, Pilch Z, Paczek L, Malmberg KJ, Wälchli S, Winiarska M, Zagozdzon R. Bajor M, et al. Among authors: pilch z. J Immunother Cancer. 2022 Jan;10(1):e002500. doi: 10.1136/jitc-2021-002500. J Immunother Cancer. 2022. PMID: 35078921 Free PMC article.
PRDX-1 Supports the Survival and Antitumor Activity of Primary and CAR-Modified NK Cells under Oxidative Stress.
Klopotowska M, Bajor M, Graczyk-Jarzynka A, Kraft A, Pilch Z, Zhylko A, Firczuk M, Baranowska I, Lazniewski M, Plewczynski D, Goral A, Soroczynska K, Domagala J, Marhelava K, Slusarczyk A, Retecki K, Ramji K, Krawczyk M, Temples MN, Sharma B, Lachota M, Netskar H, Malmberg KJ, Zagozdzon R, Winiarska M. Klopotowska M, et al. Among authors: pilch z. Cancer Immunol Res. 2022 Feb;10(2):228-244. doi: 10.1158/2326-6066.CIR-20-1023. Epub 2021 Dec 1. Cancer Immunol Res. 2022. PMID: 34853030 Free PMC article.
23 results